Publication | Closed Access

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Risk AssessmentPrognostic AssessmentPrognostic BiomarkersPrimary Myelodysplastic SyndromesAdditional Prognostic VariablePrognosisHematologyDiagnosisOutcomes ResearchMedicineEpidemiologyMyeloid Neoplasia